“How to Use Risk-Based Monitoring and Clinical CAPA to Ensure Compliance”

If your company is a sponsor or a CRO that conducts clinical research for a sponsor, how effective are your risk management and clinical CAPA processes? Are you using a risk-based approach to monitoring and CAPA to mitigate the risks during clinical research and ensure compliance?

This white paper will discuss the importance of risk-based monitoring and CAPA in clinical research within the context of the following initiatives by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA):

2013 Guidance
Clinical Trial Transformation Initiative (CTTI)
EMA’s Reflection Paper on Risk-Based Quality Management in Clinical Trials

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

By clicking here and submitting this form I agree to Daily Techinfo using the information I provide to contact me about Daily Techinfo and its affiliates' products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, as well as our privacy practices and your rights, please visit Daily Techinfo's Privacy Policy.